molecules-logo

Journal Browser

Journal Browser

Glycomics-Driven Molecular Discovery: Diagnostics, Therapeutics and Vaccines for Global Health

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Bioorganic Chemistry".

Deadline for manuscript submissions: 31 December 2026 | Viewed by 147

Special Issue Editors


E-Mail Website
Guest Editor
Institute for Biomedicine and Glycomics, Griffith University, Parklands Drive, Gold Coast, QLD 4222, Australia
Interests: drug discovery; glycobiology; chemoenzymatic transformations; chemical virology; infectious diseases; cancer; cancer biomarker discovery; anti-cancer drug discovery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute for Biomedicine and Glycomics, Griffith University, Parklands Drive, Gold Coast, QLD 4222, Australia
Interests: mass spectrometry Imaging; glycomics; glycoproteomics; cancer glycobiology; structural glycochemistry; biomarker discovery

E-Mail Website
Guest Editor
Institute for Biomedicine and Glycomics, Griffith University, Parklands Drive, Gold Coast, QLD 4222, Australia
Interests: respiratory viruses; glycovirology; host–virus interactions; antiviral drug design and development; structural biology; sialic acid
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Glycan-related molecules and glycoscience play essential roles in numerous biological processes, including molecular recognition, cell signaling, immune regulation, and host–pathogen interactions. Recent advances in glycomics, analytical chemistry, and molecular biology have greatly improved our ability to characterize glycan structures and investigate their functions at the molecular level, opening new opportunities for molecular discovery.

This Special Issue, “Glycomics-Driven Molecular Discovery: Diagnostics, Therapeutics and Vaccines for Global Health”, aims to highlight recent progress in glycan-related molecular research and innovative glycomics methodologies. Topics of interest include glycan structure and biosynthesis, glycan–protein interactions, glycoengineering, synthetic glycochemistry, and advanced analytical tools for glycomics. Particular attention will also be given to glycan-related biomolecular strategies for vaccine development, such as carbohydrate antigens, glycoconjugate vaccines, and glycan-based immunomodulatory molecules.

Inspired by the multidisciplinary research environment of the Griffith University Institute for Biomedicine and Glycomics, this Special Issue aims to advance the molecular understanding of glycan-mediated processes and support the development of innovative biomolecular approaches for diagnostics, therapeutics, and vaccines.

Prof. Dr. Mark von Itzstein
Dr. Arun Everest-Dass
Dr. Larissa Dirr
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • carbohydrate-based drug discovery
  • glycoscience
  • antiviral drugs
  • anti-infective therapeutics
  • influenza research
  • glycotherapeutics
  • drug-resistant bacteria
  • biomolecular drug design
  • cancer
  • cancer biomarker discovery
  • anti-cancer drug discovery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop